<DOC>
	<DOCNO>NCT03062059</DOCNO>
	<brief_summary>The aim study evaluate effectiveness safety intravesical gemcitabine instillation operation prevent intravesical recurrence radical nephroureterectomy upper urinary tract urothelial carcinoma .</brief_summary>
	<brief_title>The Effectiveness Safety Intravesical Gemcitabine Instillation Prevent Intravesical Recurrence</brief_title>
	<detailed_description>Study Design : Intervention Model : Single Group Assignment Masking : Open Label Primary Outcome Measures : Two year recurrence-free survival intravesical 2000mg/52.6ml gemcitabine instillation group control group . Secondary Outcome Measures : Time recurrence intravesical 2000mg/52.6ml gemcitabine instillation group control group . Overall survival intravesical 2000mg/52.6ml gemcitabine instillation group control group . Safety intravesical 2000mg/52.6ml gemcitabine instillation .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>The subject undergo nephroureterectomy due ureter renal pelvis urothelial carcinoma Male female age 18 18 year 85 year diagnose upper urinary tract urothelial carcinoma Normal bone marrow function : Hemoglobin &gt; 10 g/dL , ANC &gt; 1,500/mm3 , platelet count &gt; 100,000/mm3 Normal bladder volume function Normal liver function : Bilirubin ≤ 1.5 time upper normal limit AST/ALT ≤ 1.8 time upper normal limit Alkaline phosphatase ≤ 1.8 time upper normal limit Subjects voluntarily decide participate sign write informed consent Concomitant bladder cancer Subjects underwent treatment due bladder cancer within 3 year Prior hypersensitivity reaction history gemcitabine Neurogenic bladder Subjects underwent chemotherapy due cancer within 6 month Subjects underwent neoadjuvant chemotherapy due ureter renal pelvis urothelial carcinoma Hypersensitivity gemcitabine component gemcitabine In case coadministration gemcitabine cisplatin severe renal failure patient Moderate severe liver dysfunction renal dysfunction ( Glomerular filtration rate &lt; 30 mL/min ) Severe bone marrow suppression Severe infection Female pregnant possibility pregnancy Nursing female Interstitial pneumonia pulmonary fibrosis evident chest xray symptomatic Subjects undergoing radiotherapy chest</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>